Silly. "The S-1 will be rejected". That is not how it works. Of course it will be rejected, with comments. The company will address the comments and resubmit. Back and forth until the SEC is satisfied, then approval to proceed. The timeframe is what is unknown, not the outcome.
The RXMD barometer is now up to 204! I don't think I've ever seen it that high. Those concerned about RXMD's share price doubling in the past week are absolutely soiling themselves with panic.
There's still time for anyone still on the outside looking in to get in near the ground floor, before RXMD's share price heads for the moon and twelve cents looks like an absolute bargain.
Of course, with a bit of news, we could bypass the moon and head straight for Europa instead.
Market Data 
Markets 
